PPHM - - Press ReleaseSource: Peregrine Pharmaceuticals, Inc.
Avid Bioservices Signs Manufacturing Supply Agreement For The Production Of Four Monoclonal Antibodies
Wednesday April 2, 9:59 am ET
TUSTIN, Calif., April 2 /PRNewswire-FirstCall/ -- Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals (Nasdaq: PPHM - News), announced today that it has signed an agreement with an undisclosed biotechnology company for the cGMP manufacture of up to four monoclonal antibodies that are to be used in upcoming clinical studies.
"We are excited to bring a project of this magnitude into Avid at this time," said Jay Treat Ph.D., Avid's head of business development. "The entire Avid team looks forward to meeting the aggressive timelines required by our client. These projects are comprehensive in scope and the requirements are such that each cell line must be taken from cell bank production through process scale-up to delivery of cGMP manufactured material for clinical trials."
About Avid Bioservices
Avid Bioservices provides a full range of cGMP manufacturing services for the biotechnology and biopharmaceutical industries. Avid operates a state-of-the-art cGMP biologics contract manufacturing facility and production laboratories in Tustin, California. The company's comprehensive package of services includes highly specialized cell culture, process and analytical development work, in addition to full-scale manufacturing, purification, bulk packaging, and regulatory support. Avid has 10 years of antibody manufacturing experience producing monoclonal antibodies to support various clinical trials. The Avid facility was designed to manufacture monoclonal antibodies and recombinant proteins from mammalian expression systems, and the Company has expertise in manufacturing in batch, fed-batch and perfusion modes. For more information about Avid, please visit www.avidbio.com.
Songs I Luv
( NEWER )
( NEW )
AI
